Mereo BioPharma Group plc

MREO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 39 employees
166
SEC Filings
$0.344
Close 2026-05-29
39
Employees

Business Summary

Core Rare Disease Product CandidatesSetrusumab (BPS-804/UX143) for the Treatment of Osteogenesis ImperfectaTop-line Data from Setrusumab Phase 3 Orbit and Cosmic Studies. We do not know whether our planned clinical trials will begin on time or be completed on schedule, if at all. The commencement, data readouts and completion of clinical trials can be delayed for a number of reasons, including delays related to: inability to generate sufficient preclinical, toxicology, or other in vivo or in vit...

Latest Stock Quote

MREO 2026-05-29 $0.344 O:$0.341 H:$0.35 L:$0.3134 Vol:3.9M VWAP:$0.3288
origin leaf: 3a5ac2fca642395db8050db799c75ea329e126b29c81df17f9e12c698b314606

Next Earnings

Q2 FY2026 — expected 2026-08-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-115226EDGAR104K words
2025-03-262024-12-310000950170-25-044787EDGAR—
2024-03-272023-12-310000950170-24-037348EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274272EDGAR20K words
2025-08-122025-06-300001193125-25-178489EDGAR—
2025-05-132025-03-310000950170-25-069816EDGAR—
2024-11-122024-09-300000950170-24-124637EDGAR—
2024-08-132024-06-300000950170-24-095777EDGAR—
2024-05-152024-03-310000950170-24-060497EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001193125-26-127253EDGAR1K words
2026-03-190001193125-26-115211EDGAR—
2026-02-170001193125-26-054787EDGAR—
2026-01-120001193125-26-009829EDGAR—
2025-12-290001193125-25-332520EDGAR—
2025-11-100001193125-25-274319EDGAR—
2025-08-120000950170-25-106924EDGAR—
2025-07-100000950170-25-094921EDGAR—
2025-05-140000950170-25-071485EDGAR—
2025-05-130000950170-25-069811EDGAR—

166 total filings indexed. 147 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001719714
TickerMREO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedX0
Websitehttps://www.mereobiopharma.com
Listed2018-04-24

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bdb4a2fe97b9c1eb6d557dd98aea6d5617b08fdda57996a529f83886d20201bc
parent: 842ea4aafb08ab5a1c7c3fe36e0fde423c33db7d5bad952e181fcdbddc8a2796
content hash: 3f30dc7a177e5fa14ef5505929bb59f9a22e326cf0d48027542fc7814bfc385c
signed: 2026-06-02T19:01:56.211Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf